• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨扫描在肝细胞癌患者肝移植检查中的价值

Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant.

作者信息

Kutaiba Numan, Ardalan Zaid, Patwala Kurvi, Lau Eddie, Goodwin Mark, Gow Paul

机构信息

Radiology Department, Austin Health, Melbourne, Victoria, Australia.

Liver Transplant Unit, Austin Health, Melbourne, Victoria, Australia.

出版信息

Transplant Direct. 2018 Nov 23;4(12):e408. doi: 10.1097/TXD.0000000000000846. eCollection 2018 Dec.

DOI:10.1097/TXD.0000000000000846
PMID:30584589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6283090/
Abstract

BACKGROUND

The purpose of this study was to review the value of bone scans (BS) in the assessment of bone metastases from early-stage hepatocellular carcinoma (HCC) in patients assessed or waiting for liver transplant (LTx).

METHODS

We reviewed BS studies performed at our center for patients with early-stage HCC either being assessed for LTx, or on the waiting list for LTx, from January 2010 to May 2017. The BS findings were classified as positive, equivocal, or negative. Correlation with final outcome based on clinical and radiological follow-up was performed.

RESULTS

There were 360 BS performed in 186 patients during the study period with a mean age of 58.7 years (range, 34.9-70.4 years) and most were male patients (161/186 [86.6%]). None of the BSs resulted in delisting of patients from the LTx waiting list. Three BSs were reported as positive for metastases. All 3 were proven to be false positives on follow-up. Fourteen studies reported equivocal findings, none of which were confirmed to be metastases on follow-up. There was 1 false-negative BS: a bone metastasis was detected incidentally on magnetic resonance imaging and proven on biopsy.

CONCLUSIONS

We have demonstrated that the diagnostic yield of BS in early HCC patients who are candidates for LTx is minimal, challenging the current inclusion of BS in guidelines for staging these HCC patients.

摘要

背景

本研究的目的是回顾骨扫描(BS)在评估接受肝移植(LTx)评估或等待肝移植的早期肝细胞癌(HCC)患者骨转移中的价值。

方法

我们回顾了2010年1月至2017年5月在本中心对接受LTx评估或在LTx等待名单上的早期HCC患者进行的BS研究。BS结果分为阳性、可疑或阴性。基于临床和影像学随访与最终结果进行相关性分析。

结果

在研究期间,186例患者共进行了360次BS,平均年龄58.7岁(范围34.9 - 70.4岁),大多数为男性患者(161/186 [86.6%])。没有一次BS导致患者从LTx等待名单中除名。有3次BS报告为转移阳性。所有3次在随访中均被证明为假阳性。14项研究报告了可疑结果,随访中均未证实为转移。有1次BS为假阴性:磁共振成像偶然发现骨转移并经活检证实。

结论

我们已经证明,对于LTx候选的早期HCC患者,BS的诊断率极低,这对目前将BS纳入这些HCC患者分期指南提出了挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d041/6283090/3752f3497b0c/txd-4-e408-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d041/6283090/5daddace688d/txd-4-e408-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d041/6283090/3752f3497b0c/txd-4-e408-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d041/6283090/5daddace688d/txd-4-e408-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d041/6283090/3752f3497b0c/txd-4-e408-g006.jpg

相似文献

1
Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant.骨扫描在肝细胞癌患者肝移植检查中的价值
Transplant Direct. 2018 Nov 23;4(12):e408. doi: 10.1097/TXD.0000000000000846. eCollection 2018 Dec.
2
Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil.巴西南部肝细胞癌患者肝移植术前评估中全身骨扫描的成本效益
Clin Transplant. 2016 Apr;30(4):399-406. doi: 10.1111/ctr.12699. Epub 2016 Mar 7.
3
Limited utility of routine bone scintigraphy in the staging of patients with hepatocellular carcinoma: A cross-sectional study.常规骨扫描在肝细胞癌分期中的应用价值有限:一项横断面研究。
Ann Hepatol. 2024 Nov-Dec;29(6):101545. doi: 10.1016/j.aohep.2024.101545. Epub 2024 Aug 13.
4
A multicenter evaluation of utility of chest computed tomography and bone scans in liver transplant candidates with stages I and II hepatoma.胸部计算机断层扫描和骨扫描在I期和II期肝癌肝移植候选者中的效用的多中心评估。
Ann Surg. 2005 Apr;241(4):622-8. doi: 10.1097/01.sla.0000157267.27356.80.
5
High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.肝癌患者 Tc-99m MDP 全身骨闪烁显像检测骨转移的假阴性率高。
J Formos Med Assoc. 2012 Mar;111(3):140-6. doi: 10.1016/j.jfma.2011.01.005. Epub 2012 Feb 15.
6
Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.α-甲胎蛋白(AFP)作为肝移植后肝细胞癌复发生物标志物的诊断价值。
Clin Biochem. 2018 Feb;52:20-25. doi: 10.1016/j.clinbiochem.2017.10.011. Epub 2017 Oct 17.
7
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?针对肝硬化患者肝细胞癌开展的积极肝移植项目:是否合理?
Clin Transplant. 1999 Dec;13(6):531-5. doi: 10.1034/j.1399-0012.1999.130615.x.
8
Diagnostic Value of Technetium-99m Bone Scintigraphy in the Detection of Cervical Spine Metastases in Oncological Patients.锝 99m 骨扫描对肿瘤患者颈椎转移的诊断价值。
Spine (Phila Pa 1976). 2017 Nov 15;42(22):1699-1705. doi: 10.1097/BRS.0000000000002183.
9
Added value of Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous Tc bone scintigraphy.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-PSMA PET/CT)在新诊断前列腺癌且既往行锝骨闪烁显像患者骨转移检测中的附加价值
EJNMMI Res. 2020 Apr 8;10(1):31. doi: 10.1186/s13550-020-00618-0.
10
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.F-18 氟化钠PET-CT对肝细胞癌患者骨转移的诊断及预后评估效能
Nucl Med Commun. 2010 Jul;31(7):637-45. doi: 10.1097/MNM.0b013e3283399120.

引用本文的文献

1
Appendicular skeleton multiple bone metastasis as first manifestation of hepatocellular carcinoma.以四肢骨骼多发骨转移为首发表现的肝细胞癌
Radiol Case Rep. 2024 Sep 25;19(12):6440-6444. doi: 10.1016/j.radcr.2024.09.016. eCollection 2024 Dec.
2
Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma.肝细胞癌骨转移的新视角
Front Oncol. 2022 Jun 29;12:943866. doi: 10.3389/fonc.2022.943866. eCollection 2022.

本文引用的文献

1
International incidence and mortality trends of liver cancer: a global profile.全球肝癌发病率和死亡率趋势:国际概况。
Sci Rep. 2017 Mar 31;7:45846. doi: 10.1038/srep45846.
2
Cost-effectiveness of whole-body bone scans in the pre-liver transplant assessment of patients with hepatocellular carcinoma in Southern Brazil.巴西南部肝细胞癌患者肝移植术前评估中全身骨扫描的成本效益
Clin Transplant. 2016 Apr;30(4):399-406. doi: 10.1111/ctr.12699. Epub 2016 Mar 7.
3
EASL Clinical Practice Guidelines: Liver transplantation.欧洲肝脏研究学会临床实践指南:肝移植
J Hepatol. 2016 Feb;64(2):433-485. doi: 10.1016/j.jhep.2015.10.006. Epub 2015 Nov 17.
4
Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.肝细胞癌的全球流行病学:着重于人口统计学和区域变异性。
Clin Liver Dis. 2015 May;19(2):223-38. doi: 10.1016/j.cld.2015.01.001. Epub 2015 Feb 26.
5
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
6
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.肝细胞癌恶性骨病的自然史:一项多中心骨转移调查的最终结果
PLoS One. 2014 Aug 29;9(8):e105268. doi: 10.1371/journal.pone.0105268. eCollection 2014.
7
Evaluation of Bone Metastasis from Hepatocellular Carcinoma Using (18)F-FDG PET/CT and (99m)Tc-HDP Bone Scintigraphy: Characteristics of Soft Tissue Formation.利用(18)F-FDG PET/CT和(99m)Tc-HDP骨闪烁显像评估肝细胞癌骨转移:软组织形成特征
Nucl Med Mol Imaging. 2011 Sep;45(3):203-11. doi: 10.1007/s13139-011-0099-3. Epub 2011 Aug 5.
8
Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.成人肝移植评估:美国肝病研究协会和美国移植学会2013年实践指南
Hepatology. 2014 Mar;59(3):1144-65. doi: 10.1002/hep.26972.
9
Bone metastases in hepatocellular carcinoma: an emerging issue.肝细胞癌中的骨转移:一个新出现的问题。
Cancer Metastasis Rev. 2014 Mar;33(1):333-42. doi: 10.1007/s10555-013-9454-4.
10
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients.全身 SPECT/CT 骨显像:肿瘤患者中的诊断价值及其对患者管理的影响。
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):59-67. doi: 10.1007/s00259-013-2532-6. Epub 2013 Aug 24.